Fennec Pharmaceuticals Inc. Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 81.91%94.08%61.24%
EBT Margin -8,903.50%13,726.19%-1,321.20%-75.50%-0.15%
EBIT Margin -8,942.50%13,669.05%-1,276.94%-60.09%5.40%
EBITDA Margin 1,711.36%-2,865.57%-8,942.50%13,669.05%-1,276.94%-60.09%5.40%
Operating Margin -8,942.50%13,669.05%-1,276.94%-60.09%5.40%
Net Margin -8,903.50%13,726.19%-1,321.20%-75.50%-0.92%
FCF Margin -2,663.64%-706.23%-7,797.50%11,287.30%-1,030.70%-80.67%56.75%
Efficiency
Assets Average 3.86M2.06M2.06M1.70M2.50M16.19M25.68M18.55M22.78M26.90M35.91M
Equity Average -2.54M-3.21M-0.42M0.58M2.06M15.16M24.04M16.59M20.47M-7.10M-8.75M
Invested Capital 4.96M1.68M1.41M1.93M0.63M3.60M193.76M21.31M11.88M29.07M22.43M18.38M12.33M
Asset Utilization Ratio 0.010.791.32
Leverage & Solvency
Interest Coverage Ratio -0.00M-136.69-23.10-3.760.63
Debt to Equity -42.66-1.34-1.972.150.150.016.24
Debt Ratio 0.952.811.630.560.080.015.88
Equity Ratio -0.02-2.10-0.830.260.540.900.940.930.840.93-0.10-0.43-0.13
Times Interest Earned -0.00M-136.69-23.10-3.760.63
Valuation
Enterprise Value 5.13M18.41M2.75M10.78M29.04M24.22M18.09M25.27M130.76M103.09M115.47M161.94M114.43M228.11M285.57M146.74M
Market Capitalization 8.05M13.08M8.55M26.52M19.03M29.20M159.02M125.87M129.12M192.28M114.43M251.88M298.84M173.37M
Return Ratios
Return on Sales -89.04%137.26%-13.21%-0.75%-0.01%
Return on Capital Employed 1.05%1.68%-9.50%-1.54%-1.37%-0.48%-0.43%-0.80%-0.88%-0.66%0.09%
Return on Assets -0.93%-0.94%-1.39%-1.11%-1.15%-0.43%-0.39%-0.68%-0.78%-0.60%-0.01%
Return on Equity 1.42%0.60%6.83%-3.25%-1.39%-0.46%-0.42%-0.76%-0.87%2.26%0.05%